Pamela is Oxular’s Senior Director of Regulatory Affairs, with over 30 years of experience working in all aspects of regulatory strategy and submissions. Previously, Pamela managed and coordinated regulatory efforts at Genocea, ProMedDx and Ximedica. She has significant experience in regulatory development, strategy, and filings and brings technical experience in clinical trials design, chemistry, manufacturing, and controls and has led regulatory efforts for projects that combined novel drugs with biologic delivery devices. Additionally, Human Factor Engineering strategies for investigational drugs, biologics, medical devices, and combination products. Pamela’s industry background includes oncology, pharmacology, pharmacokinetics, and antigen-specific targeted therapeutics, as well as adoptive cell therapies and gene therapies.